Sandra Sanders-van Wijk
Dr Sandra Sanders-van Wijk graduated cum laude at the WereDi scholengemeenschap Valkenswaard in 2003 (Gymnasium/VWO). She received her master’s diploma Medicine (Geneeskunde) at Maastricht University in 2010 and obtained her doctorate/PhD thesis in 2015, entitled ‘Biomarkers in heart failure: towards individualized therapy’, focussing on clinical heart failure (HF) and biomarker research (promotor Prof. H.P. Brunner-La Rocca). She started her clinical training in cardiology (cardioloog in opleiding) in 2014 (expected end date January 2021). She won the Netherlands Heart Institute fellowship in 2018; a grant to do a 6 month post-doc abroad, spend at Northwestern University/Memorial hospital with Prof. S.J. Shah studying biomarkers in HFpEF (November 2018-April 2019). Published >20 peer-reviewed articles and 2 editorials. She has presented her research results at >10 national and international scientific conferences and was awarded ‘best speaker’ in the HF session of the Dutch cardiology conference (NVVC) in 2012. She is a reviewer for e.g. European Journal of Heart Failure.
Her current research focus is clinical research in heart failure in general and HFpEF in particular. Biomarkers (mainly circulating biomarkers) remain an area of interest and are employed to unravel disease processes, to better diagnose and to target therapy, using different holistic system biology approaches such as network & pathway analyses, mediation analysis, cluster analysis etc. Alongside biomarkers, her research focusses on general clinical and pathophysiological issues in HF, such as integrated care, eHealth applications, iron deficiency, influence of comorbidities in HF and for HFpEF specifically the focus is on inflammation and endothelial dysfunction. She has particular interest and knowledge of advanced statistical modelling/bioinformatics and database building/management (R/SPSS/Microsoft access/Cytoscape/Metascape etc).